0001179110-20-004485.txt : 20200402
0001179110-20-004485.hdr.sgml : 20200402
20200402144253
ACCESSION NUMBER: 0001179110-20-004485
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200331
FILED AS OF DATE: 20200402
DATE AS OF CHANGE: 20200402
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Otten William Robert
CENTRAL INDEX KEY: 0001704840
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36568
FILM NUMBER: 20768482
MAIL ADDRESS:
STREET 1: 3868 WHITTINGTON DR. NE
CITY: ATLANTA
STATE: GA
ZIP: 30342
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HEALTHEQUITY, INC.
CENTRAL INDEX KEY: 0001428336
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0131
BUSINESS ADDRESS:
STREET 1: 15 WEST SCENIC POINTE DRIVE
STREET 2: SUITE 100
CITY: DRAPER
STATE: UT
ZIP: 84020
BUSINESS PHONE: 801-727-1000
MAIL ADDRESS:
STREET 1: 15 WEST SCENIC POINTE DRIVE
STREET 2: SUITE 100
CITY: DRAPER
STATE: UT
ZIP: 84020
FORMER COMPANY:
FORMER CONFORMED NAME: HEALTHEQUITY INC
DATE OF NAME CHANGE: 20080227
4
1
edgar.xml
FORM 4 -
X0306
4
2020-03-31
0
0001428336
HEALTHEQUITY, INC.
HQY
0001704840
Otten William Robert
C/O HEALTHEQUITY, INC.
15 W. SCENIC POINTE DR., STE. 100
DRAPER
UT
84020
0
1
0
0
Executive VP of Sales
Common Stock
2020-03-31
4
A
0
5041
0
A
22166
D
Common Stock
2020-03-31
4
A
0
3019
0
A
25185
D
Common Stock
2020-03-31
4
A
0
4767
0
A
29952
D
Common Stock
2020-03-31
4
A
0
9224
0
A
39176
D
Stock Option (right to buy)
51.44
2027-06-21
Common Stock
43000
43000
D
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest as to 5,041 shares on the date of the meeting of the Company's compensation committee to be held in the first quarter of the fiscal year ended January 31, 2022.
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest as to 3,019 shares on the date of the meeting of the Company's compensation committee to be held in the first quarter of the fiscal year ended January 31, 2023.
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested as to 4,767 shares on March 31, 2020.
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest in four equal installments of 2,306 shares on each of March 31, 2021, 2022, 2023, and 2024.
The option is exercisable as to 21,500 shares. The remaining options become exercisable in two equal installments of 10,750 on June 21, 2020, and 2021.
/s/William Robert Otten
2020-04-02